This company has been marked as potentially delisted and may not be actively trading. Range Cancer Therapeutics ETF (CNCR) Holdings Add Compare Share Share Holdings Stock AnalysisHoldingsRatingsShort InterestTrendsBuy This Stock Top 67 CNCR HoldingsRankCompanyCurrent PriceWeightShares Held1First American Government Obligations FundN/A3.01%209,0892SMMTSummit Therapeutics$18.66-28.8%2.24%6,3283BPMCBlueprint Medicines$101.15-1.9%1.98%1,3834ITOSiTeos Therapeutics$9.98-0.5%1.95%17,3085NUVBNuvation Bio$2.12-6.2%1.92%60,9516DNAGinkgo Bioworks$6.96-4.0%1.91%16,3957FATEFate Therapeutics$1.24-6.4%1.90%131,8308RVMDRevolution Medicines$39.98+2.3%1.87%3,2559IPHAInnate Pharma$2.16-1.8%1.84%62,75210EXELExelixis$42.81+0.5%1.83%3,441 Get the Latest News and Ratings for CNCR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Range Cancer Therapeutics ETF and its competitors with MarketBeat's FREE daily newsletter. 11SDGRSchrödinger$21.63+0.9%1.83%5,36812RCUSArcus Biosciences$8.98-5.6%1.74%13,92213ELVNEnliven Therapeutics$17.84+0.6%1.74%6,05514IMCRImmunocore$36.49+4.1%1.74%4,24115BNTXBioNTech$95.71-4.5%1.72%1,26316FHTXFoghorn Therapeutics$4.14-4.2%1.72%27,69317GMABGenmab A/S$20.93-1.8%1.70%6,12418NUVLNuvalent$73.63-1.5%1.70%1,65419SWTXSpringWorks Therapeutics$46.72+0.1%1.70%2,55620TYRATyra Biosciences$9.251.70%11,86121ZYMEZymeworks$11.67+2.8%1.69%10,12622ERASErasca$1.42-2.4%1.67%87,25123IDYAIDEAYA Biosciences$20.051.67%6,65924KYMRKymera Therapeutics$29.46-2.6%1.65%3,69325IMTXImmatics$5.57+2.4%1.60%25,58026STROSutro Biopharma$0.90+0.2%1.60%136,62327YMABY-mAbs Therapeutics$4.71-0.8%1.60%26,76228HCMHUTCHMED$13.77-0.6%1.59%8,41429MRUSMerus$55.69+0.6%1.59%2,69830IBRXImmunityBio$2.67+2.7%1.58%43,77631CMPXCompass Therapeutics$2.14+0.9%1.56%54,20732CGEMCullinan Therapeutics$8.66-0.2%1.55%14,10733REGNRegeneron Pharmaceuticals$493.24-18.5%1.55%18834LEGNLegend Biotech$28.75-0.8%1.50%3,35835BCYCBicycle Therapeutics$8.22-5.5%1.49%12,76436INBXInhibrx$13.56-1.4%1.48%9,13837MRKMerck & Co., Inc.$76.86+0.6%1.48%1,34438RLAYRelay Therapeutics$3.01-2.3%1.48%36,29339ACLXArcellx$63.57-0.2%1.47%1,75140JANXJanux Therapeutics$23.71-1.4%1.47%4,043Trump Just Gave the Green Light to Rewrite Social Security? (Ad)In a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Social Security — and his plan is set to roll out July 22. What's coming next isn't about trimming waste.To see the full playbook and how it could impact everyone, click here.41KURAKura Oncology$5.68-2.4%1.46%17,47442LYELLyell Immunopharma$0.41+1.9%1.43%246,34943SNDXSyndax Pharmaceuticals$10.57-0.5%1.43%9,76944BMYBristol-Myers Squibb$48.26+0.9%1.42%2,12345CRBUCaribou Biosciences$1.08-7.3%1.41%124,88946PGENPrecigen$1.32-5.0%1.39%71,56647DAWNDay One Biopharmaceuticals$6.39-1.4%1.34%14,69348ARVNArvinas$7.23-3.6%1.32%14,64249TNGXTango Therapeutics$2.18-6.4%1.32%65,32750MGNXMacroGenics$1.37-2.1%1.29%58,43451AURAAura Biosciences$5.84-4.1%1.28%16,89552AUTLAutolus Therapeutics$1.74-0.6%1.28%69,99353NRIXNurix Therapeutics$10.62-0.2%1.28%9,14554GERNGeron$1.55+4.4%1.26%73,21155GNLXGenelux$2.47+0.4%1.22%34,15256RAPTRAPT Therapeutics$0.89-4.0%1.22%113,73857RXRXRecursion Pharmaceuticals$4.20-5.6%1.21%18,62458BMEABiomea Fusion$1.44-3.4%1.18%50,55059ZNTLZentalis Pharmaceuticals$1.22-2.8%1.17%67,40160REPLReplimune Group$8.93-4.7%1.15%10,81461XNCRXencor$7.70-0.5%1.14%9,81462ALLOAllogene Therapeutics$1.17-1.3%1.12%68,85863GLUEMonte Rosa Therapeutics$4.14-2.1%1.10%18,92864IOVAIovance Biotherapeutics$1.75-4.3%0.88%34,06165ACRVAcrivon Therapeutics$1.100.38%23,16166VORVor Biopharma$0.20+2.5%0.34%148,07367DEPOSITS WITH BROKER FOR SHORT POSITIONSN/A-0.03%1,925 Related Companies and Tools Related Companies JPMorgan Healthcare Leaders ETF Portfolio ProShares UltraShort Nasdaq Biotechnology Portfolio Horizon Kinetics Medical ETF Portfolio First Trust Nasdaq Pharmaceuticals ETF Portfolio Invesco Nasdaq Biotechnology ETF Portfolio Global X HealthTech ETF Portfolio ProShares Ultra Nasdaq Biotechnology Portfolio F/m Emerald Life Sciences Innovation ETF Portfolio Invesco Dorsey Wright Healthcare Momentum ETF Portfolio Invesco S&P SmallCap Health Care ETF Portfolio This page (NASDAQ:CNCR) was last updated on 6/1/2025 by MarketBeat.com Staff From Our PartnersTrump Just Gave the Green Light to Rewrite Social Security?In a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredBanks aren’t ready for this altcoin—are you?I've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredThe “supermetal” that could power AIWhile the headlines focus on AI models and chip speed, Elon Musk is investing in the material side of the stor...True Market Insiders | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredThe Buffett Indicator is screaming, “sell stocks, buy gold”A Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Range Cancer Therapeutics ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Range Cancer Therapeutics ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CNCR Stock Free CNCR Stock Alerts